|
1
|
Salas S, Dufresne A, Bui B, Blay JY,
Terrier P, Ranchere-Vince D, Bonvalot S, Stoeckle E, Guillou L, Le
Cesne A, et al: Prognostic factors influencing progression-free
survival determined from a series of sporadic desmoid tumors: A
wait-and-see policy according to tumor presentation. J Clin Oncol.
29:3553–3558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Camargo VP, Keohan ML, D'Adamo DR,
Antonescu CR, Brennan MF, Singer S, Ahn LS and Maki RG: Clinical
outcomes of systemic therapy for patients with deep fibromatosis
(desmoid tumor). Cancer. 116:2258–2265. 2010.PubMed/NCBI
|
|
3
|
Dômont J, Salas S, Lacroix L, Brouste V,
Saulnier P, Terrier P, Ranchère D, Neuville A, Leroux A, Guillou L,
et al: High frequency of beta-catenin heterozygous mutations in
extra-abdominal fibromatosis: A potential molecular tool for
disease management. Br J Cancer. 102:1032–1036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mullen JT, DeLaney TF, Rosenberg AE, Le L,
Iafrate AJ, Kobayashi W, Szymonifka J, Yeap BY, Chen YL, Harmon DC,
et al: β-Catenin mutation status and outcomes in sporadic desmoid
tumors. Oncologist. 18:1043–1049. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lazar AJ, Tuvin D, Hajibashi S, Habeeb S,
Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D,
Pollock RE and Lev D: Specific mutations in the beta-catenin gene
(CTNNB1) correlate with local recurrence in sporadic desmoid
tumors. Am J Pathol. 173:1518–1527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spear MA, Jennings LC, Mankin HJ, Spiro
IJ, Springfield DS, Gebhardt MC, Rosenberg AE, Efird JT and Suit
HD: Individualizing management of aggressive fibromatoses. Int J
Radiat Oncol Biol Phys. 40:637–645. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ballo MT, Zagars GK, Pollack A, Pisters PW
and Pollack RA: Desmoid tumor: Prognostic factors and outcome after
surgery, radiation therapy, or combined surgery and radiation
therapy. J Clin Oncol. 17:158–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Merchant NB, Lewis JJ, Woodruff JM, Leung
DH and Brennan MF: Extremity and trunk desmoid tumors: A
multifactorial analysis of outcome. Cancer. 86:2045–2052. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lewis JJ, Boland PJ, Leung DH, Woodruff JM
and Brennan MF: The enigma of desmoid tumors. Ann Surg.
229:866–873. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gronchi A, Casali PG, Mariani L, Lo Vullo
S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M
and Rosai J: Quality of surgery and outcome in extra-abdominal
aggressive fibromatosis: A series of patients surgically treated at
a single institution. J Clin Oncol. 21:1390–1397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crago AM, Denton B, Salas S, Dufresne A,
Mezhir JJ, Hameed M, Gonen M, Singer S and Brennan MF: A prognostic
nomogram for prediction of recurrence in desmoid fibromatosis. Ann
Surg. 258:347–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Colombo C, Miceli R, Le Péchoux C,
Palassini E, Honoré C, Stacchiotti S, Mir O, Casali PG, Dômont J,
Fiore M, et al: Sporadic extra abdominal wall desmoid-type
fibromatosis: Surgical resection can be safely limited to a
minority of patients. Eur J Cancer. 51:186–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bonvalot S, Ternès N, Fiore M, Bitsakou G,
Colombo C, Honoré C, Marrari A, Le Cesne A, Perrone F, Dunant A and
Gronchi A: Spontaneous regression of primary abdominal wall desmoid
tumors: More common than previously thought. Ann Surg Oncol.
20:4096–4102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Briand S, Barbier O, Biau D,
Bertrand-Vasseur A, Larousserie F, Anract P and Gouin F:
Wait-and-see policy as a first-line management for extra-abdominal
desmoid tumors. J Bone Joint Surg Am. 96:631–638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eastley N, Aujla R, Silk R, Richards CJ,
McCulloch TA, Esler CP and Ashford RU: Extra-abdominal desmoid
fibromatosis-a sarcoma unit review of practice, long term
recurrence rates and survival. Eur J Surg Oncol. 40:1125–1130.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shin SH, Ko KR, Cho SK, Choi YL and Seo
SW: Surgical outcome of desmoid tumors: Adjuvant radiotherapy
delayed the recurrence, but did not affect long-term outcomes. J
Surg Oncol. 108:28–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lev D, Kotilingam D, Wei C, Ballo MT,
Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS and Pollock
RE: Optimizing treatment of desmoid tumors. J Clin Oncol.
25:1785–1791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schemper M and Smith TL: A note on
quantifying follow-up in studies of failure time. Control Clin
Trials. 17:343–346. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gronchi A, Colombo C, Le Péchoux C, Dei
Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali
PG, et al: Sporadic desmoid-type fibromatosis: A stepwise approach
to a non-metastasising neoplasm-a position paper from the Italian
and the French Sarcoma Group. Ann Oncol. 25:578–583. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kasper B, Baumgarten C, Bonvalot S, Haas
R, Haller F, Hohenberger P, Moreau G, van der Graaf WT and Gronchi
A: Desmoid Working Group: Management of sporadic desmoid-type
fibromatosis: A European consensus approach based on patients' and
professionals' expertise-a sarcoma patients EuroNet and European
organisation for research and treatment of cancer/Soft tissue and
bone sarcoma group initiative. Eur J Cancer. 51:127–136. 2015.
View Article : Google Scholar : PubMed/NCBI
|
